한국어
English
日本語
中文(简体)Perjeta Injection (Pertuzumab)
30mg
Injections · Prescription medication
Roche Korea Ltd.
Pertuzumab is a targeted antibody used for the treatment of HER2-positive breast cancer.
MFDS ingredient code M258185
Pertuzumab is a humanized monoclonal antibody that specifically binds to the HER2 receptor. It is used as an anticancer agent to inhibit the growth of HER2-overexpressing cancer cells. It is primarily utilized in the treatment of HER2-positive breast cancer.
Pertuzumab binds to the HER2 receptors on the surface of cancer cells, disrupting the formation of receptor dimers. This blockage of cancer cell growth signaling leads to the inhibition of cancer cell proliferation. It also aids the immune system in recognizing and attacking cancer cells.
Approved uses differ by product. Check each product's information for its actual use.
Unlike trastuzumab, pertuzumab binds to a different site on the HER2 receptor, providing a complementary action. This results in an enhanced therapeutic effect when the two drugs are used in combination. Its characteristic feature is its specialization in targeted therapy as a monoclonal antibody.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total
30mg
Injections · Prescription medication
Roche Korea Ltd.
600mg
Injections · Prescription medication · Combination
Hankook Roche Co., Ltd.
1200mg
Injections · Prescription medication · Combination
Korea Roche Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.